Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2011; 136(21): 1123-1127
DOI: 10.1055/s-0031-1280522
DOI: 10.1055/s-0031-1280522
Prinzip & Perspektive | Review article
Diabetologie
© Georg Thieme Verlag KG Stuttgart · New York
Die Rolle der Betazelle im Diabetes mellitus
The beta cell in diabetesFurther Information
Publication History
eingereicht: 11.1.2011
akzeptiert: 17.3.2011
Publication Date:
17 May 2011 (online)
Schlüsselwörter
Betazellen des Pankreas - Typ-1-Diabetes - Typ-2-Diabetes - Therapie
Keywords
beta cells - diabetes type 1 - diabetes type 2 - treatment
Literatur
- 1 Bluestone J A, Auchincloss H, Nepom G T. et al . The Immune Tolerance Network at 10 years: tolerance research at the bedside. Nat Rev Immunol. 2010; 10 797-803
- 2 Cnop M, Welsh N, Jonas J C. et al . Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes. 2005; 54 (Suppl 2) S97-107
- 3 Eisenbarth G S. Type 1 diabetes. Molecular, cellular and clinical immunology. Book. Online Edition version 3.0 ed;. http://www.barbaradaviscenter.org/ 2010
- 4 Eizirik D L, Colli M L, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nature reviews. 2009; 5 219-226
- 5 Elsner M, Gehrmann W, Lenzen S. Peroxisome-generated hydrogen peroxide as important mediator of lipotoxicity in insulin-producing cells. Diabetes. 2011; 60 200-218
- 6 Gehrmann W, Elsner M, Lenzen S. Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic beta-cells. Diabetes, obesity & metabolism. 2010; 12 (Suppl 2) 149-158
- 7 Gurgul E, Lortz S, Tiedge M, Jörns A, Lenzen S. Mitochondrial catalase overexpression protects insulin-producing cells against toxicity of reactive oxygen species and proinflammatory cytokines. Diabetes. 2004; 53 2271-2280
- 8 Jörns A, Günther A, Hedrich H J. et al . Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat. Diabetes. 2005; 54 2041-2052
- 9 Leahy J L, Hirsch I B, Peterson K A, Schneider D. Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus. The Journal of clinical endocrinology and metabolism. 2010; 95 4206-4216
- 10 Lenzen S. Oxidative stress: the vulnerable beta-cell. Biochemical Society transactions. 2008; 36 343-347
- 11 Rahier J, Guiot Y, Goebbels R M, Sempoux C, Henquin J C. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes, obesity & metabolism. 2008; 10 (Suppl 4) 32-42
- 12 Schloot N C. Immunintervention zum Betazellerhalt bei Typ-1-Diabetes. Dtsch Med Wochenschr. 2010; 135 915-921
- 13 Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes. 1997; 46 1733-1742
- 14 Waldhäusl W, Lenzen S S. Kapitel 14. Kohlenhydratstoffwechsel. In: Schwarz S, Förster O, Peterlik M, Schauenstein K, Wick G, ed. Pathophysiologie – Molekulare, zelluläre, systemische Grundlagen von Erkrankungen.. Wien: Wilhelm Maudrich Verlag; 2007
Prof. Dr. med. Sigurd Lenzen
Institut für Klinische Biochemie
Medizinische
Hochschule Hannover
Carl-Neuberg-Str. 1
30625
Hannover
Phone: 0511/532-6525
Fax: 0511/532-3584
Email: lenzen.sigurd@mh-hannover.de